AbbVie Ireland NL B.V. (manufacturing of medicinal product, testing)

Ukraine

All drugs from this manufacturer

  • VENCLIXTO

    The drug is intended for the treatment of adult patients with chronic lymphocytic (lymphoid) leukemia (CLL), as well as newly diagnosed acute myeloid leukemia (AML).

    Dosage form: tablets, film-coated

    Active substance Dosage
    venetoclax 10 mg

    ATC: L01XX52

  • VENCLIXTO

    The drug is intended for the treatment of adult patients with chronic lymphocytic leukemia (CLL), as well as for newly diagnosed acute myeloid leukemia (AML).

    Dosage form: tablets, film-coated

    Active substance Dosage
    venetoclax 50 mg

    ATC: L01XX52

  • VENCLIXTO

    The drug is intended for the treatment of adult patients with chronic lymphocytic (lymphoid) leukemia (CLL), as well as newly diagnosed acute myeloid leukemia (AML).

    Dosage form: tablets, film-coated

    Active substance Dosage
    venetoclax 100 mg

    ATC: L01XX52